HBV

HBV Reactivation in Immunocompromised Patients (REANT STUDY)

Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide

Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)

Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults

Rapid T-cell Analysis Test in Patients With Chronic HBV and HBV/HDV Disease

Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B

Prospective Cohort Study on PEG-IFN-α-2b in Improving Clinical Cure Rate of Pediatric Patients With Chronic Hepatitis B

Prophylactic Entecavir for HBV Reactivation in Past HBV Infected Patients With Hematopoietic Stem Cell Transplantation

Liver Fibrosis in Zambian HIV-HBV Co-infected Patients

Chronic Hepatitis B Virus Infection in Zambia

Real-world Study on Liver Cancer Risk in Chronic Hepatitis B Patients With Family History of Liver Cancer

A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B

Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria

Study on the Treatment of Hepatitis B Virus(HBV) Infected Individuals With Peginterferon α-2b Combined With NA.

Access HBV Assays - European Union (EU) Clinical Trial Protocol -

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hepatitis B (China)

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Negative Hepatitis B (China)

Current Situation of Health Care in Women With HBV or HCV Infection

Antiviral Therapy in Infants With HBV Infection

The TRIple Elimination Model Of Mother-to-child Transmission Program (TRI-MOM)